Media Room

 

 

Latest News Releases
May 16, 2018

Nektar Therapeutics (Nasdaq: NKTR) today announced that new clinical and preclinical data will be presented at the upcoming 2018 American Society of Clinical Oncology Annual Meeting, which is...

May 10, 2018

Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the first quarter ended March 31, 2018. Cash and investments in marketable securities at March 31, 2018 were $333.8...

May 8, 2018

Nektar Therapeutics (NASDAQ: NKTR) today announced that it has commenced dosing patients with systemic lupus erythematosus (SLE) in a Phase 1b clinical study evaluating NKTR-358, a first-in-class...

More »

Multimedia Libraries
Media Contacts
Dan Budwick
Pure Communications, Inc.
[email protected]

More »

Follow Us on LinkedIn
Follow Us on Twitter


print email
 
 
Site Map Privacy Terms of Use Compliance Policy Trademarks Site Users Guide